Stavros Milatos

698 total citations
6 papers, 572 citations indexed

About

Stavros Milatos is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Stavros Milatos has authored 6 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Immunology. Recurrent topics in Stavros Milatos's work include RNA modifications and cancer (3 papers), RNA Research and Splicing (3 papers) and Cancer-related molecular mechanisms research (2 papers). Stavros Milatos is often cited by papers focused on RNA modifications and cancer (3 papers), RNA Research and Splicing (3 papers) and Cancer-related molecular mechanisms research (2 papers). Stavros Milatos collaborates with scholars based in Greece, United States and United Kingdom. Stavros Milatos's co-authors include Dimitris L. Kontoyiannis, George Kollias, Perry J. Blackshear, Paul Anderson, Myriam Hemberger, Vaggelis Harokopos, Maria Alexiou, Vassilis Aidinis, Anthie Yiakouvaki and Sofia Grammenoudi and has published in prestigious journals such as Blood, Molecular Cell and The Journal of Immunology.

In The Last Decade

Stavros Milatos

6 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stavros Milatos Greece	5	492	188	105	56	22	6	572
Ganqian Zhu United States	10	350 0.7×	190 1.0×	98 0.9×	36 0.6×	18 0.8×	20	476
Saibyasachi N. Choudhury United States	7	270 0.5×	254 1.4×	43 0.4×	44 0.8×	22 1.0×	7	404
Kanwal Minhas Canada	8	209 0.4×	135 0.7×	78 0.7×	56 1.0×	16 0.7×	13	344
Ana Rita Lourenço Netherlands	9	238 0.5×	106 0.6×	84 0.8×	90 1.6×	19 0.9×	11	383
Ashley N. Kamimae-Lanning United States	7	317 0.6×	88 0.5×	59 0.6×	53 0.9×	27 1.2×	8	415
Zhonghua Du China	10	553 1.1×	367 2.0×	48 0.5×	43 0.8×	28 1.3×	29	647
Wanju Jiao China	12	383 0.8×	284 1.5×	44 0.4×	54 1.0×	12 0.5×	15	490
Song Wei China	2	225 0.5×	162 0.9×	135 1.3×	57 1.0×	21 1.0×	2	411
Ting‐Miao Wu China	12	275 0.6×	245 1.3×	48 0.5×	47 0.8×	15 0.7×	17	378
Tait Huso United States	8	273 0.6×	194 1.0×	44 0.4×	55 1.0×	8 0.4×	10	359

Countries citing papers authored by Stavros Milatos

Since Specialization

Citations

This map shows the geographic impact of Stavros Milatos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stavros Milatos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stavros Milatos more than expected).

Fields of papers citing papers by Stavros Milatos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stavros Milatos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stavros Milatos. The network helps show where Stavros Milatos may publish in the future.

Co-authorship network of co-authors of Stavros Milatos

This figure shows the co-authorship network connecting the top 25 collaborators of Stavros Milatos. A scholar is included among the top collaborators of Stavros Milatos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stavros Milatos. Stavros Milatos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Kersten, Marie José, Évelyne Willems, Marte C. Liefaard, et al.. (2024). Atalanta-1: A Phase 1/2 Trial of GLPG5101, a Fresh, Stem-like, Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, for the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma. Blood. 144(Supplement 1). 93–93. 1 indexed citations

2.

Ragusa, Simone, Konstantin I. Ivanov, Nadine Zangger, et al.. (2014). PROX1 Promotes Metabolic Adaptation and Fuels Outgrowth of Wnthigh Metastatic Colon Cancer Cells. Cell Reports. 8(6). 1957–1973. 51 indexed citations

3.

Milatos, Stavros, et al.. (2009). Control of Thymic T Cell Maturation, Deletion and Egress by the RNA-Binding Protein HuR. The Journal of Immunology. 182(11). 6779–6788. 86 indexed citations

4.

Milatos, Stavros, Anthie Yiakouvaki, Maria Alexiou, et al.. (2009). The RNA-Binding Protein Elavl1/HuR Is Essential for Placental Branching Morphogenesis and Embryonic Development. Molecular and Cellular Biology. 29(10). 2762–2776. 167 indexed citations

5.

Trangas, Theoni, Stavros Milatos, Periklis Foukas, et al.. (2007). Expression of oncofetal RNA‐binding protein CRD‐BP/IMP1 predicts clinical outcome in colon cancer. International Journal of Cancer. 121(3). 486–494. 58 indexed citations

6.

Milatos, Stavros, et al.. (2005). HuR as a Negative Posttranscriptional Modulator in Inflammation. Molecular Cell. 19(6). 777–789. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact